Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Locally advanced cancers remain therapeutically challenging to eradicate. The most successful treatments continue to combine decades old non-targeted chemotherapies with radiotherapy that unfortunately increase normal tissue damage in the irradiated field and have systemic toxicities precluding furt...

Full description

Bibliographic Details
Main Authors: Adams, S.R (Author), Advani, S.J (Author), Aguilera, J. (Author), Allevato, M.M (Author), Alvarado, D. (Author), Bui, J.D (Author), Camargo, M.F (Author), Cohen, E.E.W (Author), Franiak-Pietryga, I. (Author), Hingorani, D.V (Author), Lesperance, J. (Author), Molinolo, A.A (Author), Quraishi, M.A (Author), Scanderbeg, D.J (Author), Sharabi, A.B (Author), Silvio Gutkind, J. (Author), Wang, Z. (Author)
Format: Article
Language:English
Published: Nature Research 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items